Meditope Biosciences
Pasadena, US · Founded 2011 · Delaware corporation
Find your way into Meditope Biosciences
Meditope is a biotechnology company developing SnAP technology for antibody design, with a focus on creating more efficacious, safer, and cost-efficient antibody-based therapeutic products.
Founders & leadership
ML
Martin LatterichPresident, CEO, Director
RP
Robert P. McKenzieExecutive Vice President of Business Development, Director
DS
David StoverChief Scientific Officer, Director
SH
Stephanie HsiehNamed on SEC filing
Board
HW
Heng Wei ChangBoard director
GP
George PrendergastBoard director
MG
Michael GoldbergBoard director
RK
Rob KramerBoard director
Reported raises · per SEC filings
Form D private placements$1.6M disclosed across 1 round · 2015
▶$1.6MraisedOct 2015 · 23 investors · BiotechnologyRule 506(b)
▶$1.6MraisedOct 2015 · 23 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Stephanie HsiehExecutive Officer, Director
- Heng Wei ChangDirector
- Robert McKenzieDirector
- George PrendergastDirector
- Michael GoldbergDirector
- Rob KramerDirector
- Offering amount
- $5M
- Amount sold
- $1.6M
- First sale
- Sep 2015
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Meditope Biosciences do?
- Meditope is a biotechnology company developing SnAP technology for antibody design, with a focus on creating more efficacious, safer, and cost-efficient antibody-based therapeutic products.
- How much funding has Meditope Biosciences raised?
- Meditope Biosciences has disclosed $1.6M raised across 1 round.
- Where is Meditope Biosciences headquartered?
- Meditope Biosciences is headquartered in Pasadena, US.